+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Personalized Cancer Genome Sequencing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Pre Book Price: $ 5216

Original Price: $ 5795

Personalized Cancer Genome Sequencing Market: Overview

Identification of DNA and RNA sequence in cancer cell is referred as cancer genome sequencing. Personalized cancer genome sequencing is characterization and identification of abnormal gene sequence in particular cancer cells. Globally the prevalence rate of cancer is rapidly increasing. Abnormal gene identification assists in cancer treatment and thereby guides oncologists for better treatment.

Personalized cancer genome sequencing method is a relatively new technique and thus it is under clinical trial in some of the countries to check its efficacy and effectiveness. On the other hand, in some nations these methods are practiced with strict regulatory control followed by approvals from the U.S. Food and Drug Administration (FDA) to perform personalized cancer genome sequencing.

Personalized Cancer Genome Sequencing Market: Technological and Regulatory Overview

The U.S. FDA, Centers for Disease Control and Prevention (CDC), Centers for Medicare & Medicaid Services (CMS) are some of the regulatory bodies that are regulating personalized cancer genome sequencing market in the United States. Increasing incidences of cancer globally, rising awareness about the disease and available cancer treatments, continues development of new cancer cells and increased need of speeding up of cancer genome sequencing method are some of the driving forces for the growth of the global personalized cancer genome sequencing market.

Though the market scope of personalized cancer genome sequencing test is vast, stringent regulatory procedures permit very few market players to enter into the market. Moreover, high cost involved in the research and development of such tests and solutions is restraining the growth of the global personalized cancer genome sequencing market. Global market for personalized cancer genome sequencing is categorized on the basis of type of genome sequencing namely,

  • Targeted genome sequencing
  • Whole genome sequencing

Whole genome sequencing technology has developed tremendously in the past decade. Personalized cancer genome sequencing market is shifting rapidly from targeted genome sequencing to whole genome sequencing technology due to advancement in the technology that has enabled whole genome sequencing platform with bioinformatics platforms for better analysis of the data. In addition, market for whole genome sequencing technology is increasing due to lesser cost as compared to targeted genome sequencing technique.

Personalized Cancer Genome Sequencing Market: Region-wise Outlook

Geographically, the global personalized cancer genome sequencing market can be categorized into North America, Europe, Asia-Pacific and Rest of the World (RoW). North America currently dominates this market and is followed by Europe due to factors such as highly developed technology, developed healthcare infrastructure and high disposable income. Asia-Pacific is a promising market for personalized cancer genome sequencing and is expected to undergo rapid market growth due to driving forces such as increasing purchasing power, rapidly improving healthcare infrastructure and increased awareness about the cancer and available treatment options.

In addition, the rapidly growing medical tourism industry in the Asia Pacific region especially countries such as India and China will attract global cancer patients and thus growth rate of personalized cancer genome testing market will be higher in India and China. Higher cost the personalized cancer genome test is limiting the adoption rate of personalized cancer genome testing in the Asia-Pacific region. Governments of Middle Eastern countries, gulf countries and African countries have initiated cancer awareness programs which are expected to fuel the growth of personalized cancer genome sequencing market in these countries.

Some of the market leaders contributing to the global personalized cancer genome sequencing market include Beckman Coulter Genomics, Ambry Genetics, BGI Americas Corporation, Illumina, Inc. and Cofactor Genomics.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.

To receive discount, please click on the button below.

Please click on the button below to customize this report.

Back To Top